https://european-biotechnology.net/wp-content/uploads/2025/03/Novo-Logo.jpg
562
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-10 20:21:492025-03-10 20:21:49Novo Nordisk’s obesity drug CagriSema disappoints again
https://european-biotechnology.net/wp-content/uploads/2025/03/Roche-xpandomer-synthesis-4x-1030x266-1.png
266
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-04 10:55:442025-03-04 10:55:44Roche unveils completely new sequencing approach
https://european-biotechnology.net/wp-content/uploads/2025/03/Hummingbird-2.png
944
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-04 09:30:182025-03-04 09:30:18ADC maker Callio Therapeutics secures US$187m in Series A round
https://european-biotechnology.net/wp-content/uploads/2025/02/Cean-industrial-deal-press-conference-26-feb-2025-e1740653248529-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-27 10:49:112025-02-27 10:49:11EU Commission presents Clean Industrial Deal
https://european-biotechnology.net/wp-content/uploads/2025/02/fuse-vectors-20250226-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-26 08:39:072025-02-26 08:39:07Gene therapy manufacturing: Fuse Vectors secures US$5.2m
https://european-biotechnology.net/wp-content/uploads/2025/02/Ryvu-Therapeutics-headquarters-1030x559-1.png
559
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-25 13:56:262025-02-25 13:56:26Ryvu Therapeutics extends cashflow to consolidate pipeline
https://european-biotechnology.net/wp-content/uploads/2025/02/Friedrich-Merz-1030x484-1.jpg
484
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-24 10:15:282025-02-24 10:15:28New German Chancellor wants a strong Europe
https://european-biotechnology.net/wp-content/uploads/2025/02/EG-427-nHSV-vectors-1030x404-1.png
404
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-20 06:10:162025-02-20 11:32:01French EG 427 bags €27m in Series B financing
https://european-biotechnology.net/wp-content/uploads/2025/02/Catumaxomab_mechanism.svg_-1030x467-1.png
467
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-19 14:25:582025-02-19 14:25:58Lindis Biotech selects Celonic Group for commercial manufacturing of catumaxomab
https://european-biotechnology.net/wp-content/uploads/2025/02/Cultivated-B-e1739972207647.jpg
541
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-19 11:31:332025-02-19 15:02:02Cultivated B solves fetal bovine serum problem
Scroll to top
